JP2012508698A5 - - Google Patents

Download PDF

Info

Publication number
JP2012508698A5
JP2012508698A5 JP2011535880A JP2011535880A JP2012508698A5 JP 2012508698 A5 JP2012508698 A5 JP 2012508698A5 JP 2011535880 A JP2011535880 A JP 2011535880A JP 2011535880 A JP2011535880 A JP 2011535880A JP 2012508698 A5 JP2012508698 A5 JP 2012508698A5
Authority
JP
Japan
Prior art keywords
seq
peptide
composition
amino acid
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011535880A
Other languages
English (en)
Japanese (ja)
Other versions
JP5750373B2 (ja
JP2012508698A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2009/050304 external-priority patent/WO2010054667A1/en
Publication of JP2012508698A publication Critical patent/JP2012508698A/ja
Publication of JP2012508698A5 publication Critical patent/JP2012508698A5/ja
Application granted granted Critical
Publication of JP5750373B2 publication Critical patent/JP5750373B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011535880A 2008-11-17 2009-11-17 慢性炎症性応答の調節および自己免疫疾患の処置のためのｉｌ−４由来ペプチド Active JP5750373B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200801601 2008-11-17
DKPA200801601 2008-11-17
PCT/DK2009/050304 WO2010054667A1 (en) 2008-11-17 2009-11-17 Il-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases

Publications (3)

Publication Number Publication Date
JP2012508698A JP2012508698A (ja) 2012-04-12
JP2012508698A5 true JP2012508698A5 (OSRAM) 2012-12-13
JP5750373B2 JP5750373B2 (ja) 2015-07-22

Family

ID=41510516

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011535880A Active JP5750373B2 (ja) 2008-11-17 2009-11-17 慢性炎症性応答の調節および自己免疫疾患の処置のためのｉｌ−４由来ペプチド

Country Status (12)

Country Link
US (1) US8546321B2 (OSRAM)
EP (1) EP2365983B1 (OSRAM)
JP (1) JP5750373B2 (OSRAM)
CN (1) CN102216323B (OSRAM)
AU (1) AU2009316076B2 (OSRAM)
BR (1) BRPI0921717A2 (OSRAM)
CA (1) CA2743394C (OSRAM)
ES (1) ES2620437T3 (OSRAM)
IL (1) IL212962A0 (OSRAM)
NZ (1) NZ592943A (OSRAM)
RU (1) RU2542375C2 (OSRAM)
WO (1) WO2010054667A1 (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015089217A2 (en) 2013-12-10 2015-06-18 Bionz, Llc Methods of developing selective peptide antagonists
CN103501805B (zh) 2011-01-18 2018-09-14 比奥尼斯有限责任公司 调节γ-C-细胞因子活性的组合物及方法
CN107683291B (zh) 2015-04-02 2021-11-19 英特维特国际股份有限公司 针对犬白介素-4受体α的抗体
PT3359556T (pt) 2015-10-09 2021-08-30 Bioniz Llc Modulação da atividade de citocinas gama-c
JP7752929B2 (ja) * 2017-04-07 2025-10-14 バイオニズ セラピューティクス インコーポレイテッド γｃサイトカイン活性の安定な調節剤
KR102095284B1 (ko) * 2017-05-11 2020-04-01 (주)케어젠 메토트렉세이트와 펩타이드의 결합체
ES2971898T3 (es) 2018-02-27 2024-06-10 Univ Der Johannes Gutenberg Univ Mainz Nuevos compuestos peptídicos obtenidos a partir de IL-4-/IL-13 para el tratamiento o la prevención de enfermeda-des neurodegenerativas o neuroinflamatorias
CN110746507B (zh) * 2018-12-25 2020-06-26 江苏荃信生物医药有限公司 抗人白介素4受体α单克隆抗体及其应用
CN113874075A (zh) 2019-05-03 2021-12-31 比奥尼斯有限责任公司 调节γC-细胞因子信号传导对于治疗脱发和脱发相关病症的影响
EP4419130B1 (en) 2022-01-05 2025-05-28 Serodus ApS Il-4 derived peptides for use in the treatment of obesity
EP4422659B1 (en) 2022-04-29 2025-11-05 Serodus ApS Il-4 derived peptide fragments for use in the treatment of diabetic nephropathy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05503088A (ja) * 1989-11-21 1993-05-27 ザ ユニバーシティー オブ メルボルン 抗炎症用の組成物及び方法
DE69026627T2 (de) * 1989-12-20 1996-08-22 Schering Corp., Kenilworth, N.J. Antikörperantagonisten gegen humanes interleukin-4
US6337072B1 (en) * 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
EP1156823B1 (en) * 1999-02-12 2008-10-29 The Scripps Research Institute Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
GB9912350D0 (en) * 1999-05-26 1999-07-28 European Molecular Biology Lab Embl Modified cytokine
US20030056244A1 (en) * 2000-05-02 2003-03-20 Ning Huang Feed additive compositions and methods
FR2838444B1 (fr) * 2002-04-10 2016-01-01 Neovacs Nouveaux peptides et leur application en therapeutique
WO2004096849A2 (en) * 2003-04-25 2004-11-11 University Of Manitoba Peptide-based cytokine/chemokine vaccines against allergy
EP1673386A2 (en) * 2003-10-16 2006-06-28 AplaGen GmbH Stabilized alpha-helical peptides

Similar Documents

Publication Publication Date Title
JP2012508698A5 (OSRAM)
AU2011298556B2 (en) Use of interleukin-22 in treating viral hepatitis
CN103501805B (zh) 调节γ-C-细胞因子活性的组合物及方法
EP4370146A2 (en) Lipidated peptide inhibitors of interleukin-23 receptor
RU2011121971A (ru) Пептиды-производные ил-4 для модуляции хронического воспалительного ответа и лечения аутоиммунных заболеваний
JP2016518351A5 (OSRAM)
WO2007047791A2 (en) Monomeric self-associating fusion polypeptides and therapeutic uses thereof
JP2008507298A5 (OSRAM)
CN103596584A (zh) 多取代的胰岛素
AU2023255027A1 (en) Modulating gamma-C-cytokine activity
CN104066440B (zh) 白介素-22在治疗和预防神经损伤疾病或神经退行性疾病中的用途
JP2006506942A5 (OSRAM)
JP2009112314A5 (OSRAM)
RS60053B1 (sr) Modifikator eksenatida i njegova primena
JP2014529399A5 (OSRAM)
CA3240982A1 (en) Peptide inhibitors of interleukin-23 receptor
JP7764503B2 (ja) 長時間作用型インターロイキン－１５融合タンパク質、その調製方法およびその用途
JP2011528334A5 (OSRAM)
JP2009544304A5 (OSRAM)
CA3180251A1 (en) Cytokine conjugates
JP2006523432A5 (OSRAM)
JP2014515595A5 (OSRAM)
JP2015533372A5 (OSRAM)
CN111788217A (zh) 白介素-15活性的拮抗剂肽
JP4520951B2 (ja) インスリン分泌誘導剤及びインスリン分泌誘導組成物